Market Overview

UPDATE: Goldman Sachs Downgrades Volcano Corporation to Neutral; Growth Lacking Visibility

Related VOLC
Benzinga's M&A Chatter for Wednesday June 25, 2014
Volcano to Buy AtheroMed - Analyst Blog

Goldman Sachs downgraded Volcano Corporation (NASDAQ: VOLC) from Conviction Buy to Neutral and lowered the price target from $32.00 to $25.00.

Goldman Sachs commented, "We downgrade shares of Volcano Corp (VOLC) from CL-Buy to Neutral, as recent results and Volcano's 2013 outlook point to continued pressure on the base business, slowing new growth drivers, and lower EBIT leverage. We now see Volcano as a “show me” story, having missed sales three of the last four quarters and guiding below Street three consecutive times. Further, there are limited clinical/regulatory catalysts to drive an outer year inflection point."

Volcano Corporation closed at $24.67 on Thursday.

Posted-In: Goldman SachsAnalyst Color Downgrades Analyst Ratings


Most Popular

Related Articles (VOLC)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional